Indian Innovation Systems and Emergence of Biopharmaceutical Sector : Issues and Prospects
The prospective entry of generic dominated Indian pharmaceutical sector in the ambit of new technologies is likely to give filip to emergence of strong biopharmaceutical sector.It is pertinent in this context to draw a policy roadmap which takes into account sectoral dynamics and draws upon regional and international linkages. An appropriate balance between national system of innovation (NSI) and sectoral system of innovation (SSI) would determine trajactory of growth of this sector.
|Date of creation:||Jan 2007|
|Contact details of provider:|| Postal: JG Crawford Building #13, Asia Pacific School of Economics and Government, Australian National University, ACT 0200|
Web page: http://www.eaber.org
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:eab:develo:22090. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Shiro Armstrong)
If references are entirely missing, you can add them using this form.